Pasithea Therapeutics Cor... (KTTAW)

AI Score

Unlock

0.02

0.01 (42.86%)

At close: Apr 22, 2025, 1:31 PM

Pasithea Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020
Net Income	-3.18M	-3M	-3.87M	-3.86M	-5.03M	-3.61M	-3.6M	-3.27M	-5.12M	-4.19M	-2.66M	-1.57M	630.12K	-1.53M	-727.95K	-549.61K	-47.51	-13.97
Depreciation & Amortization	162.26K	162.26K	162.26K	162.26K	162.22K	162.26K	162.26K	161.72K	-97	-1	10.79K	5.01K	1.38K	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	118.38K	147.88K	160.95K	346.48K	69.94K	126.67K	218.63K	177.02K	156.17K	-16.07K	559.33K	135.63K	156.59K	15K	n/a	n/a	n/a	n/a
Other Working Capital	455.39K	-501.06K	-531.45K	-942.26K	1.45M	129.85K	315.04K	33.85M	-830.61M	-1.16M	132.95K	-294.99K	-354.18K	n/a	n/a	n/a	3.54	n/a
Other Non-Cash Items	-1.41K	70.31K	35.62K	644.28K	429.91K	960.00	960.00	47.83K	-482.79K	1.41M	-421.7K	-785.3K	-32.51K	1.32M	16.8K	n/a	9.90	13.97
Deferred Income Tax	n/a	n/a	n/a	n/a	-394.38K	538.14K	-578.16K	n/a	n/a	n/a	n/a	n/a	-2.59M	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	455.39K	-501.06K	-531.45K	-942.26K	1.45M	129.85K	315.04K	-323.04K	1.03M	-749.8K	132.95K	-308.58K	86.49K	-354.73K	211.7K	167.76K	3.54	n/a
Operating Cash Flow	-2.44M	-3.12M	-4.04M	-4.32M	-3.31M	-2.65M	-3.48M	-3.2M	-4.42M	-4.22M	-2.38M	-2.53M	-1.74M	-548.44K	-499.44K	-381.85K	-34.06	n/a
Capital Expenditures	n/a	n/a	n/a	n/a	36.00	22.66K	-3.11K	-53.89K	-1.79M	-5.49K	-38.31K	-113.87K	-12.93K	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	54.5K	27.5K	27.5K	n/a	32.98K	-20.48K	77.06K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	54.5K	27.5K	319.62K	-4.19K	1.1M	-1.19M	-538.84K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	54.54K	50.16K	344.01K	-53.89K	-1.76M	-185.92K	38.75K	-113.87K	-12.93K	-8.57K	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	-133.34K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	-3.72B	-3.73M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-23.55K	4.54M	n/a	n/a	n/a	n/a	-130.77K	264.1K	-3.21M	-1.03M	106.54K	n/a	7M	-1.31M	n/a	n/a	390.51	n/a
Financial Cash Flow	-23.55K	4.54M	n/a	n/a	-16.89K	-4.45M	-130.77K	264.1K	-3.21M	-1.03M	106.54K	n/a	34.17M	20.55M	n/a	1.21M	390.51	n/a
Net Cash Flow	-2.44M	1.39M	-4.04M	-4.32M	-3.25M	-7.06M	-3.27M	-3.17M	-9.25M	-5.52M	-2.38M	-2.65M	32.4M	20M	-501.75K	827.08K	n/a	n/a
Free Cash Flow	-2.44M	-3.12M	-4.04M	-4.32M	-3.31M	-2.63M	-3.48M	-3.26M	-6.21M	-4.23M	-2.42M	-2.64M	-1.76M	-548.44K	-499.44K	-381.85K	-34.06	n/a